MoneyWorks4Me

Strides Arcolab’s turn black in Q2

25 Jul 2013 Evaluate

Strides Arcolab has reported results for second quarter ended June 30, 2013.

The company has reported a net profit of Rs 2.16 crore for the quarter as compared to a net loss of Rs 19.90 crore for the same quarter in the previous year. Total income of the company has decreased by 18.20% at Rs 184.04 crore for quarter under review as compared to Rs 224.99 crore for the quarter ended June 30, 2012.

Strides Pharma Scien Share Price

968.05 -17.25 (-1.75%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: